Cargando…
Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
BACKGROUND: In women of reproductive age, polycystic ovary syndrome (PCOS) constitutes the most frequent endocrine disorder. Women with PCOS are considered to typically belong to an age and sex group which is at lower risk for severe COVID-19. MAIN BODY: Emerging data link the risk of severe COVID-1...
Autores principales: | Kyrou, Ioannis, Karteris, Emmanouil, Robbins, Tim, Chatha, Kamaljit, Drenos, Fotios, Randeva, Harpal S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360476/ https://www.ncbi.nlm.nih.gov/pubmed/32664957 http://dx.doi.org/10.1186/s12916-020-01697-5 |
Ejemplares similares
-
Pan-cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS-CoV-2 infection leading to COVID-19
por: Katopodis, Periklis, et al.
Publicado: (2020) -
Neuropilin-1 as a new potential SARS-CoV-2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID-19
por: Davies, Julie, et al.
Publicado: (2020) -
Co-expression of peripheral olfactory receptors with SARS-CoV-2 infection mediators: Potential implications beyond loss of smell as a COVID-19 symptom
por: Kerslake, Rachel, et al.
Publicado: (2020) -
Uncertainty, Anxiety and Isolation: Experiencing the COVID-19 Pandemic and Lockdown as a Woman with Polycystic Ovary Syndrome (PCOS)
por: Atkinson, Lou, et al.
Publicado: (2021) -
Is There a Link between Bisphenol A (BPA), a Key Endocrine Disruptor, and the Risk for SARS-CoV-2 Infection and Severe COVID-19?
por: Zahra, Aeman, et al.
Publicado: (2020)